DA-5018. Topical analgesic

Drugs of the Future

Volumn 25, Issue 11, 2000, Pages 1131-1137

  Park, N S ^a   Seong, C M ^a   Jung, Y S ^a   Kim, W B ^a   Kim, S H ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CAPSAICIN; CAPSAVANIL; KETOPROFEN; MORPHINE; PARACETAMOL; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; HUMAN EXPERIMENT; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRURITUS; RAT; REVIEW; SKIN TOXICITY;

EID: 0034505125     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2000.025.11.599437     Document Type: Review

References (26)

1. N-Aralkylated 4-(2-aminoethoxy)phenylacetamide derivatives as potent analgesic and antiinflammatory agents
2. Synthesis of 3-arylpropylamine derivatives from aryl halides using Heck reaction
3. Capsaicin: Cellular targets, mechanisms of action, and selectivity for thin sensory neurons
4. Synthesis of homovanillic amide derivatives and their analgesic activity
5. Homovanillic amide derivatives as capsaicin analogs and their analgesic activity
6. Bioisosterism: Interaction of 4-OH to 4-NH2 in vanillin or homovanillin ring of capsaicinoids
7. Analgesic effect of DA-5018, a new capsaicin derivative, against experimental acute pain
8. Analgesic effects of DA-5018, a new capsaicin derivative, after subcutaneous injection and topical application
9. Analgesic effects of DA-5018, a new capsaicin derivative, in hyperalgesia of experimental diabetic neuropathy
10. Determination of a new non-narcotic analgesic, DA-5018, in plasma, urine and bile by high-performance liquid chromatography
11. Pharmacokinetics of a non-narcotic analgesic, DA-5018, in rats
12. Stability, blood partition and protein binding of DA-5018, a new non-narcotic analgesic
13. 14C-DA-5018 after subcutaneous injection and topical application
14. General pharmacology of DA-5018, a new capsaicin derivative
15. Studies on the local irritation of DA-5018, a new capsaicin derivative
16. A study on the contact allergic skin sensitization of 0.3% DA-5018 cream, a non-narcotic analgesic agent with guinea pig maximization test
17. Primary skin and eye irritation test of 0.3% DA-5018 cream, a new non-narcotic analgesic
18. Acute toxicity study of DA-5018, a non-narcotic analgesic agent
19. Four-week oral toxicity study of DA-5018, a non-narcotic analgesic agent
20. Mutagenicity of DA-5018, a non-narcotic analgesic agent
21. Physical dependence on DA-5018, a non-narcotic analgesic agent
22. Analgesic action mechanism of DA-5018, a new capsaicin derivative: Relationship to opiate receptors and prostanoids
23. A possible mechanism of analgesic action of DA-5018, a new capsaicin derivative: Capsaicin-like effect on the release of substance P